Showing results (1131-1140 of 1,170) with videos related to
Sort By:
Pageof 117
Molecular Cancer Therapeutics|April 14, 2007
Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analoguesSwee Y Sharp, Chrisostomos Prodromou, Kathy Boxall, et al.Nature Chemical Biology|October 27, 2015
A selective chemical probe for exploring the role of CDK8 and CDK19 in human diseaseTrevor Dale, Paul A Clarke, Christina Esdar, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 12, 2010
Rapid screening of methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effectsM W M Wassenberg, J A J W Kluytmans, A T A Box, et al.Pigment Cell & Melanoma Research|October 4, 2018
Frontiers in pigment cell and melanoma researchFabian V Filipp, Stanca Birlea, Marcus W Bosenberg, et al.The American Journal of Tropical Medicine and Hygiene|February 28, 2022
Investigating Flubendazole as an Anthelmintic Treatment for Guinea Worm (Dracunculus medinensis): Clinical Trials in Laboratory-Reared Ferrets and Domestic Dogs in ChadChristopher A Cleveland, Kayla B Garrett, Erin K Box, et al.Journal of Medicinal Chemistry|February 14, 2015
Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT signaling from a cell-based pathway screenAurélie Mallinger, Simon Crumpler, Mark Pichowicz, et al.Elife|December 10, 2016
Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinasesPaul A Clarke, Maria-Jesus Ortiz-Ruiz, Robert TePoele, et al.Nature Communications|June 16, 2023
Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2Katherine U Gaynor, Marina Vaysburd, Maximilian A J Harman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2026
Radiation Oncology-Biology Integration Network (ROBIN): Bridging the gap between biological research and clinical practiceFabiana Gregucci, Christine Lee-Poturalski, Madelyn Dirrim, et al.Journal of Medicinal Chemistry|November 25, 2011
Structure-guided evolution of potent and selective CHK1 inhibitors through scaffold morphingJohn C Reader, Thomas P Matthews, Suki Klair, et al.Pageof 117